Today.com – Oct. 4
At the Moffitt Cancer Center in Tampa, the bell has been available outside the entrance of the infusion center since 2011. Krissy Frantz, RN, the clinic operations manager, said she’s never received any negative feedback from patients about it, but would address any concerns if they arose and appreciates the feedback.
Time – Oct. 4
A friend who is a cancer doctor advised her against getting the surgery and referred her to Dr. Brian Czerniecki at Moffitt Cancer Center, who told her about a pioneering study he was conducting to test a completely new way of fighting breast cancer–not solely with chemotherapy, radiation or surgery but by harnessing the power of her own immune system.
Fortune – Oct. 4
“We actually saw a suggestion that there might be an increased risk with very long-term and high-frequency use of non-aspirin NSAIDs,” Tworoger, a senior researcher at the Moffitt Cancer Center, told me in an interview by phone this afternoon.
Reuters Health – Oct. 3
Dr. Bijal Shah, a hematology and oncology specialist at Moffitt Cancer Center in Tampa, Florida, agrees with the findings. "There are very few AYA- specific trials," he told Reuters Health by email. "Usually such trials are 'pediatric' (with age range of 0-30 y), or 'adult' (with age range of 18-99 y). This makes it very difficult to really understand the impact of treatment changes in this population."
Healio – Oct. 4
“Our findings expand on two consortium studies showing that daily aspirin is related to lower ovarian cancer risk. Many people take a low-dose aspirin daily for heart disease prevention,” Shelley S. Tworoger, PhD, associate center director of population science at Moffitt Cancer Center, said in the release.
Health News Digest – Oct. 4
In a new study published in European Urology, Moffitt Cancer Center researchers, along with colleagues at Harvard T.H. Chan School of Public Health and Brigham and Women’s Hospital in Boston, demonstrated that a baseline prostate-specific antigen (PSA) level obtained from black men between ages 40 and 60 can strongly predict future development of prostate cancer and its most aggressive forms for years after testing.
Bioengineer.org – Oct. 4
A new study co-led by Moffitt Cancer Center found that women who reported taking a low-dose aspirin every day had a 23 percent lower risk of ovarian cancer compared to nonaspirin users.
Oncology Learning Network – Oct. 4
“The goal of this trial was to find an alternative to cisplatin that would be as effective at controlling the cancer, but with fewer side effects. We were surprised by the loss of tumor control with cetuximab,” said Andy Trotti, MD, lead investigator of the trial and Physician and Senior Member, Moffitt Cancer Center, Tampa, Florida.
WNDU – Oct. 4
The other CELLSEARCH system is at the Moffitt Cancer Center in Tampa.
NewKerala.com – Oct. 5
Let’s Win! – Oct. 3
It is possible to keep setting the clock back on the progression of the disease,” says Hodul, surgical oncologist at Moffitt Cancer Center in Tampa, Florida, and Associate Professor in the Division of Oncologic Sciences at the University of South Florida.
Tampa Bay Newspapers – Oct. 3
Representatives from Hooters Management Corp. recently presented a $50,000 donation to Moffitt Cancer Center, which included proceeds from the 2017 Give a Hoot program. In addition, two of Hooters' founders have pledged matching donations for a total of $150,000 to Moffitt Cancer Center.
Wiener dogs race, Paddle in Pink, Pirate Festival, Oktoberfest events top this weekend
TC Palm – Oct. 3
The fifth annual Paddle in Pink is 8 a.m. to 6 p.m. Saturday at Costa d’Este Beach Resort & Spa at 3244 Ocean Drive in Vero Beach. … Proceeds benefit the Moffitt Cancer Center Foundation. For more information, call 321-438-8733 or go to www.paddleinpink.org.
Targeted Oncology – Oct. 2
In an interview with Targeted Oncology, on Hematologic Malignancies, Pinilla-Ibarz, a senior member of Moffitt Cancer Center, discussed updates in the treatment of patients with CLL.
News Medical – Oct. 3
"Midlife PSA predicts subsequent development of aggressive prostate cancer better than either family history or race," said co-first author and Moffitt epidemiologist Travis Gerke, Sc.D.
Clinical Oncology News – Oct. 3
“In a population with few, if any, remaining treatment options, the clinical benefit of axicabtagene is substantial, regardless of the exposure to previous therapies,” reported Frederick L. Locke, MD, the program co-leader in immunology at Moffitt Cancer Center, in Tampa, Fla..
Technology Networks – Oct. 3
Researchers from the Moffitt Cancer Center have used a two-pronged approach to identify a previously unknown mechanism of action (MOA) for the drug midostaurin in lung cancer. The team combined a large-scale proteomics study with a novel data integration method to identify drug-protein interactions, the team discovered three protein targets, TBK1, PDPK1 and AURKA, previously unknown to be significant for midostaurin's MOA in lung cancer cells.
WFLA – Oct. 2
Spaninato undergoes treatment at Moffitt Cancer Center. Her beef is with Medicare provider LogistiCare.
Patch – Oct. 3
Outside of school, she volunteers her time at Moffitt Cancer Center. She is an amazing student-athlete that is an example of balance and service
Fox 13 – Oct. 1
It’s all part of the program called Moffitt Healthy Kidz, which is meant to help young people understand the importance of early detection.
Florida Trend – Oct. 2
“Our talent and services go beyond the district,” says Aurelio M. Fernandez, CEO of Memorial Healthcare System, which began a partnership with Moffitt Cancer Center to provide comprehensive care for leukemia and lymphoma patients. “We have more than 6 million people in the region. But if you deliver a quality product, it attracts people from the entire country."
Tampa Bay Times – Oct. 1
So Moffitt Cancer Center hosted 50 Tampa Catholic High School students for a special program, Moffitt Healthy KIDZ goes PINK, to help kick off the start of breast cancer awareness month Monday (Oct. 1).
OncLive – Oct. 1
In an interview during the 2018 OncLive® State of the Science Summit on Hematologic Malignancies, Pinilla-Ibarz, a senior member of Moffitt Cancer Center, discussed updates in the treatment of patients with CLL.
Tampa Bay Times – Oct. 1
“Our goal here,” said certified breast care nurse Cheryl Whitman, “is we do provide the same care here as many get down at Moffitt.” She referred to H. Lee Moffitt Cancer Center & Research Hospital in Tampa, nationally ranked for women’s cancer treatment.
Self Magazine – Sept. 28
Most people do well with treatment, especially if their cancer is caught early and hasn’t spread to other organs, Dr. Bilchik says. "There are high rates of cure with this disease, and surgery is only done if there is a local recurrence," Sarah Hoffe, M.D., section head of GI Radiation Oncology at Moffitt Cancer Center, tells SELF.
WMAZ – Oct. 1
Jon got to ring the bell at Moffitt Cancer Center in February of 2018. His treatment was over, but this journey is not. Also posted to WMAZ
Patch – Oct. 1
Come and play your favorite Arcade games on Saturday, October 6 from 11 a.m. to 4 p.m. at Minnreg Hall, Largo, during Tampa Bay's first-ever Play for a Cure Arcade Tournament, Benefiting Moffitt Cancer Center.
Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.